companydata.dkACESION PHARMA ApS: Financial statements 2017
CVR: 34083738
ACESION PHARMA ApS (CVR 34083738) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -17,450,508 and a net result of DKK -23,972,490 compared with DKK -18,262,257 the year before. Equity amounted to DKK -9,918,160. The company had 12 employees in the financial year.
- Gross Profit
- -17,450,508 kr.
- Profit/Loss
- -23,972,490 kr.
- Equity
- -9,918,160 kr.
- Total Assets
- 22,816,866 kr.
- Employees
- 12
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -17.5 mio. | -24 mio. | -9.9 mio. | 12 |
| 2016 | - | -14.4 mio. | -18.3 mio. | 14.1 mio. | - |
| 2015 | - | -8.5 mio. | -9.8 mio. | 1.5 mio. | - |
| 2014 | - | -4.7 mio. | -6.5 mio. | 3.8 mio. | - |
| 2013 | - | -4.8 mio. | -6.5 mio. | -556 t. | - |
Find more companies like ACESION PHARMA ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2017
As of October 25, 2017, Georgios Trichas has joined the board of directors of ACESION PHARMA ApS.
As of October 25, 2017, Lars Gredsted has left the board of directors of ACESION PHARMA ApS.
ACESION PHARMA ApS has published its annual report for 2016. Gross profit came to DKK -14,393,708, and the net result was DKK -18,262,257.
As of March 17, 2017, Jakob Dynnes Hansen is registered as director of ACESION PHARMA ApS.
As of January 13, 2017, Lars Gredsted has joined the board of directors of ACESION PHARMA ApS.
About ACESION PHARMA ApS
ACESION PHARMA ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2011. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Anders Gaarsdal Holst. The company's owners include Novo Holdings A/S, Canaan XII L.P. and Alpha Wave Ventures II, LP. The company has 14 employees. In 2025, the company reported a net result of DKK -59,597,000 compared with DKK -43,033,000 the year before. Equity amounted to DKK 276,067,000.